Molecular Oncology Diagnostics Laboratory led by Dr. Bryan Lo to open

July 29, 2014

A new era of personalized cancer care began this past week as The Ottawa Hospital and the Eastern Ontario Regional Laboratory Association (EORLA) welcomed research geneticist Dr. Bryan Lo who will open Ottawa’s first lab devoted to treating and studying the genetics of cancer. Dr. Lo most recently worked in the Department of Research at the biotechnology firm Genentech in San Francisco, California. He now will assume the position of Lead Scientist and Medical Director for The Ottawa Hospital’s Molecular Oncology Diagnostics Laboratory. The new facility will function as a clinical diagnostic lab and a research lab. It will help to revolutionize cancer diagnosis and treatment by allowing health-care providers to analyze the genetic flaws inside tumour cells and tailor therapies to a patient’s individual type of cancer. This will improve cancer care by giving providers the ability to predict which drugs would work best for particular patients and which drugs would not be beneficial. In addition, wait times for test results will decrease as tissue samples no longer have to be sent to other labs in Canada or the United States for sophisticated genetic testing. Now, it can all be done at The Ottawa Hospital. Read the news release.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)